Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Celiac Disease | 9 | 2019 | 749 | 1.850 |
Why?
|
Ventricular Remodeling | 26 | 2011 | 1280 | 1.640 |
Why?
|
Matrix Metalloproteinases | 14 | 2011 | 409 | 1.480 |
Why?
|
Matrix Metalloproteinase 9 | 9 | 2010 | 696 | 0.890 |
Why?
|
Myocardial Contraction | 12 | 2009 | 1659 | 0.810 |
Why?
|
Myocardium | 23 | 2011 | 4969 | 0.780 |
Why?
|
Myocardial Infarction | 23 | 2011 | 11323 | 0.770 |
Why?
|
Ventricular Function, Left | 15 | 2011 | 3411 | 0.720 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 9 | 2011 | 102 | 0.720 |
Why?
|
Matrix Metalloproteinase 2 | 10 | 2010 | 474 | 0.630 |
Why?
|
Heart Arrest, Induced | 4 | 2006 | 363 | 0.630 |
Why?
|
Matrix Metalloproteinase 14 | 7 | 2011 | 64 | 0.620 |
Why?
|
Glutens | 2 | 2015 | 221 | 0.580 |
Why?
|
Myocardial Reperfusion Injury | 5 | 2009 | 496 | 0.450 |
Why?
|
Endopeptidases | 1 | 2015 | 827 | 0.420 |
Why?
|
Immunomodulation | 1 | 2015 | 540 | 0.410 |
Why?
|
Diet, Gluten-Free | 4 | 2019 | 265 | 0.410 |
Why?
|
Myocytes, Cardiac | 8 | 2010 | 1641 | 0.400 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 4 | 2005 | 154 | 0.380 |
Why?
|
Swine | 21 | 2011 | 5763 | 0.380 |
Why?
|
Duodenum | 1 | 2012 | 476 | 0.370 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2010 | 240 | 0.360 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 8896 | 0.360 |
Why?
|
Endotoxins | 1 | 2010 | 558 | 0.330 |
Why?
|
Finite Element Analysis | 1 | 2010 | 409 | 0.330 |
Why?
|
Endothelin-1 | 2 | 2006 | 317 | 0.320 |
Why?
|
Models, Cardiovascular | 2 | 2010 | 1005 | 0.320 |
Why?
|
Heart Conduction System | 2 | 2010 | 1030 | 0.310 |
Why?
|
Aortic Aneurysm, Thoracic | 6 | 2010 | 621 | 0.310 |
Why?
|
Aorta, Thoracic | 6 | 2010 | 1045 | 0.300 |
Why?
|
Fibrinolysin | 3 | 2011 | 136 | 0.300 |
Why?
|
Oligopeptides | 4 | 2015 | 1276 | 0.300 |
Why?
|
Aprotinin | 3 | 2011 | 87 | 0.300 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2005 | 142 | 0.270 |
Why?
|
Cytokines | 5 | 2017 | 7189 | 0.270 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2004 | 72 | 0.270 |
Why?
|
Animals, Newborn | 1 | 2010 | 2877 | 0.270 |
Why?
|
Protein Kinase C | 2 | 2006 | 1292 | 0.260 |
Why?
|
Transcription, Genetic | 3 | 2010 | 7965 | 0.260 |
Why?
|
Electric Stimulation Therapy | 1 | 2010 | 624 | 0.250 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2010 | 859 | 0.250 |
Why?
|
Heart-Assist Devices | 3 | 2010 | 1238 | 0.250 |
Why?
|
Heart Injuries | 1 | 2005 | 200 | 0.250 |
Why?
|
Antifibrinolytic Agents | 3 | 2010 | 248 | 0.250 |
Why?
|
Radiation Injuries, Experimental | 1 | 2003 | 97 | 0.250 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2011 | 991 | 0.240 |
Why?
|
Muscle Cells | 1 | 2004 | 200 | 0.240 |
Why?
|
Hydroxamic Acids | 2 | 2003 | 507 | 0.240 |
Why?
|
Intestinal Mucosa | 2 | 2017 | 3070 | 0.220 |
Why?
|
Heart | 4 | 2011 | 4315 | 0.220 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2002 | 255 | 0.220 |
Why?
|
Random Allocation | 7 | 2010 | 2455 | 0.210 |
Why?
|
Enzyme Activation | 6 | 2010 | 3879 | 0.210 |
Why?
|
Microdialysis | 6 | 2011 | 167 | 0.210 |
Why?
|
Temperature | 2 | 2006 | 2144 | 0.210 |
Why?
|
Arrhythmias, Cardiac | 2 | 2010 | 2144 | 0.210 |
Why?
|
Enzyme Inhibitors | 5 | 2005 | 3936 | 0.200 |
Why?
|
Ventricular Pressure | 3 | 2010 | 219 | 0.200 |
Why?
|
Biocompatible Materials | 1 | 2008 | 1725 | 0.190 |
Why?
|
Animals | 50 | 2011 | 170486 | 0.190 |
Why?
|
Cysteine Proteinase Inhibitors | 2 | 2010 | 217 | 0.190 |
Why?
|
Serine Proteinase Inhibitors | 2 | 2011 | 186 | 0.180 |
Why?
|
Disease Models, Animal | 18 | 2010 | 18375 | 0.180 |
Why?
|
Enzyme Induction | 4 | 2006 | 515 | 0.170 |
Why?
|
Tranexamic Acid | 2 | 2010 | 143 | 0.170 |
Why?
|
Collagen | 10 | 2011 | 2687 | 0.170 |
Why?
|
Cardiopulmonary Bypass | 3 | 2010 | 1085 | 0.160 |
Why?
|
Isoenzymes | 4 | 2006 | 1812 | 0.160 |
Why?
|
Hemodynamics | 10 | 2010 | 4211 | 0.160 |
Why?
|
Gene Expression Regulation, Enzymologic | 4 | 2010 | 1268 | 0.150 |
Why?
|
Computer Simulation | 1 | 2010 | 6048 | 0.150 |
Why?
|
Hookworm Infections | 1 | 2015 | 13 | 0.140 |
Why?
|
Promoter Regions, Genetic | 5 | 2010 | 6068 | 0.140 |
Why?
|
Caspases | 3 | 2010 | 940 | 0.140 |
Why?
|
Endothelins | 2 | 2006 | 136 | 0.140 |
Why?
|
Irritable Bowel Syndrome | 1 | 2020 | 397 | 0.140 |
Why?
|
Echocardiography | 6 | 2010 | 5139 | 0.130 |
Why?
|
Cardioplegic Solutions | 2 | 2004 | 113 | 0.130 |
Why?
|
Rewarming | 2 | 2004 | 62 | 0.130 |
Why?
|
Catheter Ablation | 2 | 2005 | 2506 | 0.130 |
Why?
|
Peptides | 2 | 2006 | 4424 | 0.130 |
Why?
|
Transglutaminases | 1 | 2015 | 185 | 0.130 |
Why?
|
Aspartate Aminotransferases | 1 | 2015 | 413 | 0.130 |
Why?
|
Heart Failure | 5 | 2010 | 10040 | 0.130 |
Why?
|
Enterocytes | 1 | 2015 | 234 | 0.120 |
Why?
|
Ventricular Dysfunction, Left | 5 | 2010 | 2042 | 0.120 |
Why?
|
Alanine Transaminase | 1 | 2015 | 600 | 0.120 |
Why?
|
Tight Junctions | 1 | 2015 | 333 | 0.110 |
Why?
|
Mice | 20 | 2011 | 80876 | 0.110 |
Why?
|
Fibrinolysis | 2 | 2010 | 350 | 0.110 |
Why?
|
Fibroblasts | 4 | 2010 | 4299 | 0.110 |
Why?
|
Probiotics | 1 | 2015 | 339 | 0.110 |
Why?
|
Heart Ventricles | 7 | 2010 | 3851 | 0.110 |
Why?
|
Sus scrofa | 3 | 2010 | 455 | 0.100 |
Why?
|
GTP-Binding Proteins | 1 | 2015 | 959 | 0.100 |
Why?
|
Durapatite | 1 | 2011 | 162 | 0.100 |
Why?
|
Protease Inhibitors | 2 | 2006 | 830 | 0.100 |
Why?
|
Heart Rate | 3 | 2010 | 4094 | 0.090 |
Why?
|
Diastole | 2 | 2010 | 836 | 0.090 |
Why?
|
Systole | 2 | 2010 | 993 | 0.090 |
Why?
|
Heart Septal Defects | 1 | 2010 | 181 | 0.090 |
Why?
|
Compliance | 1 | 2009 | 116 | 0.090 |
Why?
|
Acetylcysteine | 1 | 2010 | 287 | 0.090 |
Why?
|
Forkhead Transcription Factors | 1 | 2017 | 1600 | 0.090 |
Why?
|
Metalloendopeptidases | 3 | 2005 | 420 | 0.090 |
Why?
|
Calpain | 1 | 2009 | 157 | 0.090 |
Why?
|
Time Factors | 12 | 2010 | 41038 | 0.090 |
Why?
|
Dilatation, Pathologic | 3 | 2010 | 517 | 0.090 |
Why?
|
Microspheres | 1 | 2011 | 801 | 0.090 |
Why?
|
Thoracotomy | 1 | 2010 | 361 | 0.090 |
Why?
|
Cardiotonic Agents | 2 | 2009 | 550 | 0.090 |
Why?
|
beta-Galactosidase | 2 | 2006 | 623 | 0.090 |
Why?
|
Cardiac Pacing, Artificial | 2 | 2010 | 847 | 0.080 |
Why?
|
Interferon-gamma | 1 | 2017 | 3245 | 0.080 |
Why?
|
Atrial Fibrillation | 1 | 2006 | 4454 | 0.080 |
Why?
|
Injections, Intralesional | 1 | 2008 | 283 | 0.080 |
Why?
|
Microinjections | 1 | 2008 | 366 | 0.080 |
Why?
|
Immunohistochemistry | 8 | 2011 | 11790 | 0.080 |
Why?
|
Up-Regulation | 4 | 2010 | 4353 | 0.080 |
Why?
|
Dipeptides | 1 | 2009 | 402 | 0.080 |
Why?
|
Vaccines | 1 | 2015 | 719 | 0.080 |
Why?
|
Protein Kinase C-epsilon | 1 | 2006 | 51 | 0.080 |
Why?
|
Food Hypersensitivity | 1 | 2014 | 619 | 0.080 |
Why?
|
Drug Discovery | 1 | 2015 | 1066 | 0.080 |
Why?
|
Dogs | 2 | 2010 | 4059 | 0.080 |
Why?
|
Probability | 2 | 2010 | 2474 | 0.080 |
Why?
|
Hemostatics | 1 | 2009 | 224 | 0.080 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2006 | 59 | 0.080 |
Why?
|
Chemokines | 1 | 2010 | 954 | 0.070 |
Why?
|
Myocardial Reperfusion | 2 | 2006 | 349 | 0.070 |
Why?
|
Vasoconstriction | 1 | 2009 | 610 | 0.070 |
Why?
|
Stroke Volume | 5 | 2010 | 4522 | 0.070 |
Why?
|
Hyperkalemia | 2 | 2004 | 207 | 0.070 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2011 | 1178 | 0.070 |
Why?
|
Extracellular Matrix | 2 | 2011 | 1794 | 0.070 |
Why?
|
Transforming Growth Factor beta | 2 | 2010 | 1993 | 0.070 |
Why?
|
Connexin 43 | 1 | 2006 | 220 | 0.070 |
Why?
|
Pacemaker, Artificial | 1 | 2010 | 762 | 0.070 |
Why?
|
Mice, Transgenic | 5 | 2010 | 9927 | 0.070 |
Why?
|
Isotonic Solutions | 1 | 2004 | 118 | 0.060 |
Why?
|
Sheep | 4 | 2011 | 1484 | 0.060 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2003 | 144 | 0.060 |
Why?
|
Male | 28 | 2017 | 349524 | 0.060 |
Why?
|
Reperfusion Injury | 1 | 2010 | 1071 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3464 | 0.060 |
Why?
|
Reference Values | 2 | 2008 | 5041 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2014 | 2029 | 0.060 |
Why?
|
Depression, Chemical | 1 | 2002 | 207 | 0.060 |
Why?
|
Calcium Chloride | 3 | 2010 | 81 | 0.060 |
Why?
|
Guanidines | 1 | 2003 | 205 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2878 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8024 | 0.060 |
Why?
|
Adrenomedullin | 1 | 2002 | 87 | 0.060 |
Why?
|
Purinergic P1 Receptor Antagonists | 1 | 2002 | 46 | 0.060 |
Why?
|
Endocardium | 1 | 2003 | 267 | 0.060 |
Why?
|
Radio Waves | 1 | 2003 | 248 | 0.060 |
Why?
|
Humans | 21 | 2020 | 708843 | 0.060 |
Why?
|
Tachycardia, Ventricular | 1 | 2010 | 1177 | 0.060 |
Why?
|
Gene Deletion | 3 | 2006 | 2838 | 0.050 |
Why?
|
Creatine Kinase | 1 | 2003 | 713 | 0.050 |
Why?
|
Recovery of Function | 2 | 2010 | 2950 | 0.050 |
Why?
|
Latent TGF-beta Binding Proteins | 2 | 2011 | 43 | 0.050 |
Why?
|
Equipment Design | 1 | 2010 | 3627 | 0.050 |
Why?
|
Sulfones | 1 | 2003 | 454 | 0.050 |
Why?
|
Blood Pressure | 4 | 2010 | 8528 | 0.050 |
Why?
|
Analysis of Variance | 3 | 2010 | 6530 | 0.050 |
Why?
|
Disease Progression | 7 | 2006 | 13298 | 0.050 |
Why?
|
Cicatrix | 1 | 2005 | 689 | 0.050 |
Why?
|
Heart Atria | 1 | 2006 | 1286 | 0.050 |
Why?
|
Aging | 2 | 2009 | 8358 | 0.050 |
Why?
|
Female | 20 | 2017 | 375205 | 0.050 |
Why?
|
Hypothermia, Induced | 1 | 2004 | 715 | 0.050 |
Why?
|
Electrocardiography | 2 | 2010 | 6386 | 0.050 |
Why?
|
Quadriceps Muscle | 2 | 2010 | 127 | 0.050 |
Why?
|
Infusions, Intravenous | 3 | 2010 | 2303 | 0.040 |
Why?
|
Protein Transport | 1 | 2005 | 2059 | 0.040 |
Why?
|
Kidney | 4 | 2011 | 6888 | 0.040 |
Why?
|
Fibrosis | 3 | 2010 | 1947 | 0.040 |
Why?
|
Cells, Cultured | 2 | 2006 | 20170 | 0.040 |
Why?
|
Ethanol | 1 | 2005 | 1245 | 0.040 |
Why?
|
Mice, Inbred C57BL | 5 | 2010 | 22989 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2010 | 14836 | 0.040 |
Why?
|
Organ Size | 1 | 2003 | 2317 | 0.040 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 2 | 2010 | 65 | 0.040 |
Why?
|
Spectrometry, Fluorescence | 2 | 2010 | 725 | 0.040 |
Why?
|
Coronary Artery Bypass | 2 | 2005 | 2376 | 0.040 |
Why?
|
Caspase 3 | 2 | 2010 | 805 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17218 | 0.040 |
Why?
|
RNA, Messenger | 5 | 2011 | 13314 | 0.040 |
Why?
|
Inflammation | 1 | 2017 | 10019 | 0.040 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2005 | 1195 | 0.040 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2002 | 823 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2010 | 3984 | 0.040 |
Why?
|
Receptor, Angiotensin, Type 1 | 2 | 2009 | 152 | 0.040 |
Why?
|
Area Under Curve | 2 | 2010 | 1688 | 0.040 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2017 | 316 | 0.040 |
Why?
|
Personal Satisfaction | 1 | 2020 | 596 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2019 | 61932 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2010 | 19423 | 0.030 |
Why?
|
Actins | 3 | 2010 | 2191 | 0.030 |
Why?
|
Myocardial Ischemia | 1 | 2005 | 2114 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2015 | 533 | 0.030 |
Why?
|
Stress, Mechanical | 2 | 2009 | 1714 | 0.030 |
Why?
|
Models, Animal | 2 | 2011 | 2221 | 0.030 |
Why?
|
HLA-DQ Antigens | 1 | 2014 | 233 | 0.030 |
Why?
|
Cell Survival | 1 | 2004 | 6156 | 0.030 |
Why?
|
Genes, Reporter | 2 | 2009 | 1611 | 0.030 |
Why?
|
Troponin I | 2 | 2010 | 632 | 0.030 |
Why?
|
Angiotensin II | 2 | 2009 | 921 | 0.030 |
Why?
|
Postoperative Period | 2 | 2010 | 1843 | 0.030 |
Why?
|
Mitral Valve Insufficiency | 1 | 2002 | 1355 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2017 | 1712 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2011 | 11239 | 0.030 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2011 | 112 | 0.030 |
Why?
|
Thallium Radioisotopes | 1 | 2011 | 150 | 0.030 |
Why?
|
Smad2 Protein | 1 | 2011 | 170 | 0.030 |
Why?
|
Survival | 1 | 2011 | 162 | 0.030 |
Why?
|
Middle Aged | 8 | 2017 | 213752 | 0.030 |
Why?
|
Fibrillar Collagens | 1 | 2010 | 40 | 0.030 |
Why?
|
Likelihood Functions | 1 | 2014 | 989 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4941 | 0.020 |
Why?
|
Gelatinases | 1 | 2010 | 96 | 0.020 |
Why?
|
Th17 Cells | 1 | 2017 | 742 | 0.020 |
Why?
|
Intestine, Small | 1 | 2017 | 1235 | 0.020 |
Why?
|
Ultrasonography | 3 | 2010 | 5918 | 0.020 |
Why?
|
Calcium | 1 | 2003 | 5825 | 0.020 |
Why?
|
Enzyme Precursors | 1 | 2010 | 186 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2017 | 1719 | 0.020 |
Why?
|
Coronary Disease | 1 | 2005 | 6127 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 10857 | 0.020 |
Why?
|
Microbubbles | 1 | 2010 | 118 | 0.020 |
Why?
|
Lac Operon | 1 | 2009 | 252 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 3093 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2015 | 1539 | 0.020 |
Why?
|
Myosins | 1 | 2010 | 425 | 0.020 |
Why?
|
Microscopy, Confocal | 2 | 2005 | 2046 | 0.020 |
Why?
|
Injections | 1 | 2011 | 876 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2009 | 685 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2010 | 6850 | 0.020 |
Why?
|
Elastin | 1 | 2009 | 332 | 0.020 |
Why?
|
Chronic Disease | 1 | 2003 | 8992 | 0.020 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2010 | 445 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20308 | 0.020 |
Why?
|
Mice, Knockout | 3 | 2011 | 15274 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3376 | 0.020 |
Why?
|
Elasticity | 1 | 2009 | 666 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2009 | 1472 | 0.020 |
Why?
|
Apoptosis | 3 | 2009 | 10085 | 0.020 |
Why?
|
Adult | 5 | 2017 | 211041 | 0.020 |
Why?
|
Microscopy, Video | 1 | 2006 | 259 | 0.020 |
Why?
|
Troponin | 1 | 2010 | 505 | 0.020 |
Why?
|
Signal Transduction | 4 | 2011 | 23950 | 0.020 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2005 | 41 | 0.020 |
Why?
|
Matrix Metalloproteinases, Membrane-Associated | 1 | 2005 | 18 | 0.020 |
Why?
|
Electric Conductivity | 1 | 2006 | 428 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-3 | 1 | 2005 | 41 | 0.020 |
Why?
|
Gap Junctions | 1 | 2006 | 267 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2011 | 935 | 0.020 |
Why?
|
Heart Block | 1 | 2006 | 410 | 0.020 |
Why?
|
Aged | 5 | 2017 | 161488 | 0.020 |
Why?
|
Organ Specificity | 1 | 2009 | 2064 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 2005 | 576 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2945 | 0.020 |
Why?
|
Liver | 2 | 2010 | 7622 | 0.020 |
Why?
|
Heart Septum | 1 | 2005 | 322 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3562 | 0.020 |
Why?
|
Age Factors | 2 | 2013 | 18712 | 0.020 |
Why?
|
Creatine Kinase, MB Form | 1 | 2003 | 221 | 0.020 |
Why?
|
Electrolytes | 1 | 2004 | 289 | 0.010 |
Why?
|
Adrenergic beta-Agonists | 1 | 2004 | 359 | 0.010 |
Why?
|
Benzenesulfonates | 1 | 2003 | 175 | 0.010 |
Why?
|
Hematologic Tests | 1 | 2004 | 232 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2015 | 21194 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2017 | 3055 | 0.010 |
Why?
|
Heart Function Tests | 1 | 2003 | 336 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 1977 | 0.010 |
Why?
|
Alabama | 1 | 2002 | 90 | 0.010 |
Why?
|
Angiotensin I | 1 | 2002 | 59 | 0.010 |
Why?
|
Chymases | 1 | 2002 | 105 | 0.010 |
Why?
|
Xanthines | 1 | 2002 | 122 | 0.010 |
Why?
|
Cell Hypoxia | 1 | 2005 | 686 | 0.010 |
Why?
|
Rabbits | 1 | 2009 | 5163 | 0.010 |
Why?
|
Endosomes | 1 | 2005 | 531 | 0.010 |
Why?
|
Fluoroscopy | 1 | 2006 | 901 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5456 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3558 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 16008 | 0.010 |
Why?
|
Immunoblotting | 1 | 2005 | 1795 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2004 | 15053 | 0.010 |
Why?
|
Kinetics | 1 | 2009 | 6796 | 0.010 |
Why?
|
Renin | 1 | 2002 | 614 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6765 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2006 | 1632 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8712 | 0.010 |
Why?
|
Neurotransmitter Agents | 1 | 2003 | 632 | 0.010 |
Why?
|
Biological Transport | 1 | 2003 | 2146 | 0.010 |
Why?
|
Quality of Life | 1 | 2020 | 11594 | 0.010 |
Why?
|
Cell Separation | 1 | 2004 | 1835 | 0.010 |
Why?
|
Cell Communication | 1 | 2006 | 1653 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2005 | 1928 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10566 | 0.010 |
Why?
|
Young Adult | 2 | 2017 | 55940 | 0.010 |
Why?
|
Infant | 2 | 2010 | 34261 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 13274 | 0.010 |
Why?
|
Blood Glucose | 1 | 2013 | 6255 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2003 | 1682 | 0.010 |
Why?
|
Coronary Circulation | 1 | 2003 | 1652 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2003 | 1399 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2009 | 4466 | 0.010 |
Why?
|
Contrast Media | 1 | 2010 | 5267 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2015 | 71483 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2006 | 2913 | 0.010 |
Why?
|
Echocardiography, Transesophageal | 1 | 2003 | 1109 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 2002 | 1132 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 14712 | 0.010 |
Why?
|
Gene Expression | 1 | 2009 | 8014 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2011 | 4969 | 0.010 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 1478 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 2004 | 1899 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 8968 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2006 | 14215 | 0.010 |
Why?
|
Protein Binding | 1 | 2006 | 9639 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 13647 | 0.010 |
Why?
|
Piperazines | 1 | 2003 | 2532 | 0.010 |
Why?
|
Survival Analysis | 1 | 2006 | 10507 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 18748 | 0.010 |
Why?
|
Wound Healing | 1 | 2003 | 2800 | 0.010 |
Why?
|
Rats | 1 | 2009 | 25094 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2003 | 2277 | 0.010 |
Why?
|
Macrophages | 1 | 2006 | 5784 | 0.010 |
Why?
|
Body Weight | 1 | 2002 | 4680 | 0.010 |
Why?
|
Length of Stay | 1 | 2004 | 6257 | 0.010 |
Why?
|
Adolescent | 1 | 2017 | 84718 | 0.010 |
Why?
|
United States | 1 | 2015 | 67165 | 0.010 |
Why?
|
Phenotype | 1 | 2004 | 16306 | 0.000 |
Why?
|
Risk Factors | 1 | 2013 | 69553 | 0.000 |
Why?
|
Prospective Studies | 1 | 2004 | 50597 | 0.000 |
Why?
|